Latest News

Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • February 20, 2019 10:19 AM | Anonymous

    February 20, 2019, MedPage Today 

    The goal of this study was to determine the safety and efficacy of umbilical cord blood (UCB) grafts using NiCord, a single cord blood unit expanded ex vivo with nicotinamide, and transplanted into patients with a variety of hematological malignancies after myeloablative conditioning. Researchers compared NiCord's activity to historical data on 146 closely-matched transplant patients from the Center for International Blood and Marrow Transplant Research (CIBMTR). 

    Read more.

  • February 20, 2019 10:17 AM | Anonymous

    February 20, 2019, HealthDay News 

    Younger U.S. women are suffering heart attacks at a higher rate now than 20 years ago — even while the picture has improved for younger men. Those are the key findings from a new study of four U.S. communities, in which researchers report the heart attack rate among women younger than 55 has steadily inched upward since 1995. In contrast, the rate dipped among men in that age group. 

    Read more.

  • February 20, 2019 10:16 AM | Anonymous

    February 20, 2019, HemOnc Tdoay  

    Women who have a family history of certain types of cancer should be screened to determine if they have an increased risk for BRCA1 or BRCA2 mutations, according to a draft recommendation from the U.S. Preventive Services Task Force. Women with an ethnicity or ancestry linked to these genetic mutations also should be screened.  

    Read more.

  • February 20, 2019 10:12 AM | Anonymous

    February 20, 2019, MedPage Today 

    Early screening for gestational diabetes was not linked with a decrease in the risk of adverse perinatal outcomes in a cohort of obese women, a researcher said here.

    Read more.

  • February 19, 2019 10:48 AM | Anonymous

    February 19, 2019, MedPage Today 

    Women who received non-opioid analgesia following cesarean delivery had a lower mean pain score than women who received opioids along with other pain medicine, a researcher said here.

    A small randomized trial found mean pain scores lower for women in the non-opioid group versus the opioid group at 2-4 weeks postpartum, meaning opioids for pain may be inferior (12.3 vs 15.9, respectively, adjusted mean difference 4.8, 95% CI -2.1 to 11.9), reported Jenifer Dinis, MD, of McGovern Medical School at the University of Texas, Health Science Center in Houston.

    Read more.
  • February 15, 2019 8:04 AM | Anonymous

    February 15, 2019, Medscape 

    The treatment of HER2-positive, early stage breast cancer has taken "one more step toward personalized medicine and reduced mortality" thanks to the results of the KATHERINE trial, according to Daniel Hayes, MD, a medical oncologist at the University of Michigan Rogel Cancer Center in Ann Arbor. He says the trial is a "game changer" for patients who have residual disease after initial drug treatment and surgery, in an editorial published online in the New England Journal of Medicine. 

    Read more.

  • February 13, 2019 11:13 AM | Anonymous

    February 13, 2019, MedPage Today  

    Treatment with direct-acting antivirals (DAAs) for hepatitis C virus (HCV) was associated with a "rapid and significant" decrease in risk for all-cause mortality and hepatocellular carcinoma (HCC), a French prospective study found. But the study could not clarify the long-term effects of these agents on liver decompensation. 

    Read more.

  • February 12, 2019 7:35 AM | Anonymous

    February 12, 2019, MedPage Today 

    Nonsuspicious adnexal masses had a low risk of malignancy, and many of the lesions resolved spontaneously, according to a large prospective study of conservative management. During a median follow-up of 27 months, fewer than 1 percent of 1,919 patients had an invasive malignancy or borderline tumor at surgery. Torsion and cyst rupture also occurred in fewer than 1 percent of cases. 

    Read more.

  • February 11, 2019 11:12 AM | Anonymous

    February 11, 2019, Endorcine Today 

    The risk for developing a "more aggressive" form of breast cancer is higher among women with type 2 diabetes compared with women without diabetes, according to findings published in Diabetes Care. Use of insulin analogues did not increase risk for more aggressive breast cancers, according to researchers. 

    Read more.

  • February 11, 2019 11:04 AM | Anonymous

    February 11, 2019, Medscape

    Robotic mastectomy for invasive breast cancer was performed for the first time in the United States last year, but the move toward this surgical approach ground to a halt soon afterward. The first such operation was performed in September 2018 by Stephen Chagares, MD, at the Monmouth County Medical Center in Long Branch, New Jersey.

    Read more.

Powered by Wild Apricot Membership Software